Sectors
InSilico Genomics offers academics and industry the ability to compare their data on parts of the human genome with public datasets.
The deal is WM's first corporate venturing exit and Joe Vaillancourt, vice-president of WM's organic growth group venture investing, by email said: "We actually have four exits underway. It has been a pretty busy year."
EDF-backed Electranova Capital invests in French rechargeable battery maker.
French biopharmaceutical company Transgene invests in antibody start-up
More than 250 corporate venturing powerbrokers have gathered in London, UK, to attend the Global Corporate Venturing (GCV) Symposium starting today.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
